Breakwater Capital Group Increases Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Breakwater Capital Group boosted its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 16.5% during the fourth quarter, Holdings Channel.com reports. The fund owned 5,266 shares of the exchange traded fund’s stock after purchasing an additional 744 shares during the quarter. Breakwater Capital Group’s holdings in SPDR S&P Biotech ETF were worth $474,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. FMR LLC lifted its position in shares of SPDR S&P Biotech ETF by 13.6% in the third quarter. FMR LLC now owns 6,940 shares of the exchange traded fund’s stock valued at $686,000 after acquiring an additional 830 shares in the last quarter. Beaton Management Co. Inc. acquired a new position in SPDR S&P Biotech ETF in the 3rd quarter valued at $212,000. Prairie Wealth Advisors Inc. lifted its holdings in SPDR S&P Biotech ETF by 3.6% in the 2nd quarter. Prairie Wealth Advisors Inc. now owns 6,616 shares of the exchange traded fund’s stock valued at $613,000 after purchasing an additional 231 shares in the last quarter. Robinson Value Management Ltd. boosted its stake in SPDR S&P Biotech ETF by 1.2% during the 3rd quarter. Robinson Value Management Ltd. now owns 13,452 shares of the exchange traded fund’s stock worth $1,329,000 after purchasing an additional 155 shares during the last quarter. Finally, Envestnet Asset Management Inc. grew its holdings in shares of SPDR S&P Biotech ETF by 12.5% during the second quarter. Envestnet Asset Management Inc. now owns 186,400 shares of the exchange traded fund’s stock worth $17,281,000 after buying an additional 20,685 shares in the last quarter.

SPDR S&P Biotech ETF Trading Down 2.8 %

XBI opened at $86.66 on Wednesday. The firm has a market capitalization of $6.61 billion, a PE ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a twelve month low of $81.14 and a twelve month high of $105.47. The firm’s 50-day moving average price is $95.28 and its 200 day moving average price is $97.10.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.